Breaking News

Alcami Expands Biologics Footprint with Investment in Durham

$10 million investment doubles laboratory footprint and enhances large molecule and cell and gene therapy analytical service offering.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Alcami, a U.S.-based pharmaceutical contract development and manufacturing organization (CDMO), is investing $10 million to expand its laboratory operation in Durham, NC. The investment adds over 6700 square feet to the existing laboratory footprint, new equipment, and capabilities to enhance drug substance and drug product characterization capabilities for biologics in all phases of development, and the capacity to support parenteral manufacturing projects and stand-alone analytical clients.   ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters